CVE:GIT Gitennes Exploration (GIT) Stock Price, News & Analysis C$0.43 -0.03 (-6.52%) As of 01/27/2025 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Gitennes Exploration Stock (CVE:GIT) Get Gitennes Exploration alerts:Sign Up Key Stats Today's RangeC$0.40▼C$0.4350-Day RangeC$0.43▼C$0.4352-Week RangeC$0.05▼C$0.55Volume27,500 shsAverage Volume62,626 shsMarket CapitalizationC$3.98 millionP/E RatioN/ADividend Yield5.17%Price TargetN/AConsensus RatingN/A Company Overview Gitennes Exploration Inc., a junior mineral exploration company, acquires and explores for mineral properties. The company primarily explores for gold, copper, and silver deposits. It holds interests in the New Mosher, Maxwell, and JMW gold properties in northern Quebec; the Snowbird gold property in northern British Columbia; and three gold/copper properties in the Gaspé region of Quebec, Canada, as well as a royalty interest in the Urumalqui silver property in Peru. The company is based in Vancouver, Canada. Read More Receive GIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gitennes Exploration and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GIT Stock News HeadlinesGitennes Exploration (CVE:GIT) Stock Price Passes Above Fifty Day Moving Average - Time to Sell?July 14, 2026 | americanbankingnews.comREV Exploration Taps Hydrogen Veteran Steve Halabura as Lead Technical AdvisorJanuary 24, 2026 | theglobeandmail.comNNVC: FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles — a disease with no approved antiviral treatment currently on the market. NV-387 is designed as a broad-spectrum antiviral with potential applications across RSV, influenza, coronaviruses, Mpox, and more. With Phase II trials advancing and measles cases resurging globally, NNVC is entering a notable inflection point.July 22 at 1:00 AM | Equiscreen (Ad)REV Exploration Corp. Expands JMW Gold Property in QuebecNovember 19, 2025 | msn.comREV Exploration Receives Authorization For Drilling For Jmw Gold Property In Chibougamau CampOctober 15, 2025 | juniorminingnetwork.comREV Exploration Acquires Drill-Ready Natural Hydrogen Project in AlbertaMay 22, 2025 | juniorminingnetwork.comREV Acquires Drill-Ready Natural Hydrogen Project in AlbertaMay 22, 2025 | finance.yahoo.comREV Exploration jump-starts search for hydrogen in AlbertaMay 16, 2025 | msn.comSee More Headlines GIT Stock Analysis - Frequently Asked Questions How have GIT shares performed this year? Gitennes Exploration's stock was trading at C$0.43 at the beginning of 2026. Since then, GIT shares have increased by 0.0% and is now trading at C$0.43. How do I buy shares of Gitennes Exploration? Shares of GIT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Gitennes Exploration own? Based on aggregate information from My MarketBeat watchlists, some other companies that Gitennes Exploration investors own include Warren Resources (WRESQ), ODP (ODP), Linn Energy (LINEQ), Gevo (GEVO), Shake Shack (SHAK) and Towerstream (TWER). Industry, Sector and Symbol Stock ExchangeCVE SectorBasic Materials Industry Gold Sub-IndustryN/A Current SymbolCVE:GIT CIKN/A Webwww.gitennes.com Phone+1-604-6827970FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on Equity-306.61% Return on Assets-154.93% Debt Debt-to-Equity Ratio25.52 Current Ratio0.13 Quick Ratio0.99 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.02 per share Price / Cash Flow25.00 Book ValueC($0.05) per share Price / Book-8.60Miscellaneous Outstanding Shares9,250,000Free FloatN/AMarket CapC$3.98 million OptionableNot Optionable Beta0.28 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (CVE:GIT) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredNNVC: FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...Freedom Financial | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredYour First Trade Playbook is expiringMost beginners stay stuck on the sidelines for years because no one shows them the simple steps between being ...Profits Run | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gitennes Exploration Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gitennes Exploration With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.